Upload
giampaolo-pagliuca
View
218
Download
0
Embed Size (px)
Citation preview
New technologies to quality control and selection of stem cells
for applications in regenerative medicine and cell therapy
Winner
Is it best sample we can ever inject?
QC matters!Stem cells QC & production for Regenerative Medicine
Market Cell Therapy New Era
2500
1500
500
Increase x20
2012 2016 2018
Market forecast(million $)
Organ regeneration$ 350 billion
Regenerative Medicine$ 100 billion
Market2015 Technologies
$ 118 millions
Stem cells$ 1.3 billion
US
• No manipulations of cells
• Costs, process times reduction
• Passing regulatory barriers
Lab R&D
Cell banks
Cell factories
ClinicsHospitals
Clinical Surgery
Clients&Needs
Exclusive features
No cell manipulation
High purity
High cell recovery
Real time monitoring
Our solutionA novel method to tag-less isolate and sort living cells
Celector®
Concept&Prototype
WHAT WE NEEDMarketing, Sales, and Business Scale-up Partners
Towards the ready-to-marketProduct Development, Finance, Investments
1st VC investment- 200k
Debt capital- 20k UNINDUSTRIA- 20k CARISBO
Debt capital- 190k CARISBO
POR “innovative start-up”- 190k ER 2nd VC investment
- 400k
R&D
Validation
Industrialization
Foundation € 1 M Today
The CompanyManagers, R&D team, and Equity
Academics73.67%
VC15%
Incubator11.33%Foundation
Academics45.68%
VC47.30%
Incubator7.02%
Today
Martina Rossi BiotechnologistApplications Developer
Ilaria VigliottaBiotechnologistProduct Developer
Silvia ZiaBiomedical ScientistApplications Manager
Marco VaglivielloMechanical EngineerProduct Manager
Prof. Pierluigi ReschiglianCEO
Prof. Barbara Roda
Prof. Andrea Zattoni
Dr. M. LuisaNolliProject Manager